<DOC>
	<DOC>NCT00856622</DOC>
	<brief_summary>The purpose of this study is to demonstrate that fixed combination of latanoprost and timolol (PhXA41) has better IOP lowering effect than the individual monotherapies.</brief_summary>
	<brief_title>A Study Demonstrating The Effect Of Latanoprost In Combination With Timolol, Latanoprost Alone And Timolol Alone On Eye Pressure In Open Angle Glaucoma Or Ocular Hypertension In Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma, Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Unilateral or bilateral primary open angle glaucoma, capsular glaucoma, pigmentary glaucoma or ocular hypertension. Patients currently on IOP reducing therapy: IOP greater than or equal to 25mmHg (two IOP determinations at prestudy separated by at least one hour) OR Patients without IOP reducing therapy: IOP greater than or equal to 30mmHg (two IOP determinations at prestudy separated by at least one hour). History of acute angle closure or closed/barely open anterior chamber angle. Current use of contact lenses. Ocular surgery or argon laser trabeculoplasty (ALT) within three months prior to prestudy visit. Ocular inflammation/infection occurring within three months prior to prestudy visit. Hypersensitivity to benzalkonium chloride or to any other component of the study drug solutions. Other abnormal ocular condition or symptom preventing the patient from entering the study, according to the investigator's judgement. Cardiac failure, sinus bradycardia, second and third degree of atrioventricular block. (The routines for prescribing topical Bblocking agents will be followed. Bronchial asthma, history of bronchial asthma or chronic obstructive pulmonary disease. (The routines for prescribing topical Bblocking agents will be followed). Pregnancy Women of childbearing potential who has not used adequate contraceptive methods during the last three months. Inability to adhere to treatment/visit plan. Have participated in any other clinical study within one month prior to prestudy visit.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>open-angle glaucoma ocular hypertension glaucoma</keyword>
</DOC>